ScienBio Technology Obtains Patent for Manufacturing Method of Cross-linked Hyaluronic Acid Gel Containing Special Corticosteroid
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
ScienBio Technology announced that it has received patent approval from Taiwan's Intellectual Property Office for its invention titled 'Manufacturing Method for Cross-linked Hyaluronic Acid Gel Containing Special Corticosteroid and Cross-linked Hyaluronic Acid Gel.' This patent is expected to contribute to new product development and enhance the company's competitiveness.
AI Analysis
Frequently Asked Questions
- Q: What is the official name of the company that obtained the patent?
- A: The official name of the company is ScienBio Technology Co., Ltd.
- Q: What is the specific title of the approved patent application?
- A: The title is 'Manufacturing Method for Cross-linked Hyaluronic Acid Gel Containing Special Corticosteroid and Cross-linked Hyaluronic Acid Gel'.
- Q: What is the application number of the approved invention patent?
- A: The application number of the approved invention patent is 113132817.
- Q: Which office reviewed and approved this patent application?
- A: The patent application was reviewed and approved by Taiwan's Intellectual Property Office (TIPO).
- Q: What are the expected benefits of this patent for the company's products?
- A: It can be used for new product development or improvement of product efficacy, increasing product diversity.